A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults From a Large U.S. Managed Care Population
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- Eli Lilly and Company
- Enrollment
- 254432
- Primary Endpoint
- Incidence of suicide attempt resulting in medical encounter or hospitalization.
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
The primary objective of the study is to estimate the incidence of suicide attempts resulting in a medical encounter or hospitalization in seven propensity matched cohorts of subjects: patients treated with duloxetine for depression, patients treated with one of three other antidepressants or antidepressant classes (venlafaxine, SSRIs, or TCAs) for depression, patients treated with multiple antidepressants for depression (either concurrently or consecutively), depressed patients with no pharmacologic treatment, and a non-depressed general population sample.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 years or older at index date
- •Have at least 6 months of continuous enrollment data prior to index date.
- •Have complete medical, facility, and pharmacy records (the latter of which will include complete quantity and days supplied information).
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Incidence of suicide attempt resulting in medical encounter or hospitalization.
Time Frame: Endpoint
Secondary Outcomes
- Relative risk of suicide attempt resulting in medical encounters or hospitalization(Endpoint)